Donate For Public and Patients Store Search

S021 - What's New and What's True in Lasers

Saturday, March 2; 9:00 AM - 12:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Describe new light based devices and procedures.
  • Evaluate light based procedures and combinations for dermatologic indications.
  • Define limitations of current light based treatments and areas for future development.

Description

What's New and What's True in Lasers will explore evaluation of new devices as well as innovative uses of devices that have been available. Speakers with both clinical and research experience will share their expertise on topics including: the newest vascular lesion treatment options, resurfacing using current technologies, optimizing treatment of pigmented lesions, device treatment of acne, energy based devices for women's genitourinary health, combining devices and injectables, lasers, micro needles and laser assisted drug deliver for scars and rejuvenation and strategies for treating Fitzpatrick Skin types 4-6. Novel cutting edge approaches will be highlighted and discussion encouraged.

Disclosures

  • Alexiades, Macrene, MD, PhD: Allergan, Inc – A(H), I(Grants/Research Funding); Lumenis – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding), I(Grants/Research Funding);
  • Avram, Mathew M., MD, JD: Alastin Skincare, Inc – C(Fees); Allergan, Inc – C(Fees); Cytrellis Biosystems, Inc – C(ST); Invasix – C(Fees); Masters of Aesthetics, Inc. – F(Fees); Merz Aesthetics – C(Fees); Sciton Inc. – A(Fees); Sienna Biopharmaceuticals – A(Fees); Zalea, LLC – C(Fees); Zeltiq Aesthetics – C(Fees);
  • Geronemus, Roy G., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(Grants/Research Funding); ArchiMedus – I(Grants/Research Funding); Candela Corporation – A(Grants/Research Funding), I(Grants/Research Funding); Cearna, Inc – A(Grants/Research Funding); Cynosure, Inc – A(Grants/Research Funding), I(Grants/Research Funding); Cytrellis Biosystems, Inc – A(Grants/Research Funding), I(ST), SH(ST); Endo Pharmaceuticals – I(Grants/Research Funding); Kerastem – I(Grants/Research Funding); Lutronic – A(Grants/Research Funding), I(Grants/Research Funding); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – I(Grants/Research Funding); New York Stem Cell Foundation – I(Grants/Research Funding); Revance Therapeutics, Inc. – I(Grants/Research Funding); Sciton Inc. – I(Grants/Research Funding); Sienna Biopharmaceuticals – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding), I(Grants/Research Funding);
  • Kauvar, Arielle N.B., MD: ArchiMed – I(Grants/Research Funding); Lumenis – C(Fees); Novoxel – I(Grants/Research Funding); Sebcaia, Inc – C(Fees); Syneron, Inc. – I(Grants/Research Funding);
  • Kelly, Kristen Marie, MD: Allergan, Inc – C(H), I(Grants/Research Funding); Asclepion Laser Technologies GmbH – O(EQ); Candela Corporation – O(EQ), O(NC); New Star Lasers – I(EQ); R2 Dermatology, Inc. – I(EQ); Reliant Technologies, Inc. – O(EQ); Sciton, Inc. – C(H), SP(H); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – C(H); Thermage – O(EQ); Vivosight – C(EQ);
  • Kilmer, Suzanne L., MD: Aesthetics Biomedical – I(H); Alastin Skincare, Inc – I(H); Allergan, Inc – I(Grants/Research Funding); BTL Industries – A(Grants/Research Funding); Cutera, Inc. – I(Grants/Research Funding); Cynosure, Inc. – I(Grants/Research Funding); Cytrellis Biosystems, Inc – A(Grants/Research Funding); Dominion Aesthetics – I(H); Galderma USA – A(H); Lumenis – I(Grants/Research Funding); Lutronics, Inc. – I(Grants/Research Funding); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – A(H); Pulse Biosciences – A(Grants/Research Funding); R2 Dermatology, Inc. – I(Grants/Research Funding); Sciton Inc. – A(Grants/Research Funding); Sienna Labs, Inc. – A(H); Solta Medical – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding);
  • Ortiz, Arisa, MD: Aerolase – A(H), O(EQ); Alastin Skincare, Inc – C(H); Allergan, Inc – A(H), SH(NC), SP(H); BTL Industries – O(EQ); Cutera, Inc. – C(H); Guthy-Renker – SP(S); InMode MD Ltd – A(H), SP(H); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Rodan and Fields – A(H); Sciton Inc. – A(H), SP(H); Sienna Biopharmaceuticals – I(Grants/Research Funding); Ulthera – Data Safety Monitoring Board(H);
  • Tanghetti, Emil A., MD: Accure Medical, LLC – I(Grants/Research Funding); Allergan, Inc. – A(H), C(H), I(Grants/Research Funding), SP(H); Amgen – I(Grants/Research Funding); Bayer – SP(H); Celgene Corporation – I(Grants/Research Funding); Coherus Biosciences – I(Grants/Research Funding); Cynosure, Inc. – C(EQ), I(EQ); DUSA Pharmaceuticals, Inc. – C(H), I(Grants/Research Funding), SP(H); Galderma Research & Development, LLC – C(H), I(Grants/Research Funding), SP(H); Leo Pharma A/S – I(Grants/Research Funding); Leo Pharma Inc – SP(H); Lilly ICOS LLC – I(Grants/Research Funding); Valeant Pharmaceuticals International – I(Grants/Research Funding), SP(H);
  • Waibel, Jill S., MD: Alma Lasers – SP(H); Aquavit Pharmaceuticals – I(SO); Candela Corporation – SP(H); Cutera, Inc. – I(Grants/Research Funding); Lumenis – I(H); Lutronics, Inc. – I(Grants/Research Funding); Michelson Diagnostics Ltd. – I(EQ); Regenx – C(Grants/Research Funding); Sciton Inc. – I(Grants/Research Funding); Sebacia, Inc. – I(Grants/Research Funding); Vivosight – I(Grants/Research Funding); Zeltiq Aesthetics – SP(H);
Schedule
Saturday, March 2
9:00 AM
Dr. Tanghetti / Device treatment of acne: what’s true and what’s new
9:20 AM
Dr. Geronemus / Resurfacing Update
9:40 AM
Dr. Kauvar / Optimizing Treatment of Pigmented Lesions
10:00 AM
Dr. Kelly / Old and New Vascular Lesions Treatment
10:20 AM
Dr. Alexiades / Update on Devices for Women's Genitourinary Health
10:40 AM
Dr. Ortiz / Combining Devices and Injectables to Enhance Results
11:00 AM
Dr. Waibel / Lasers, micro needles and laser assisted drug delivery for scars and rejuvenation
11:20 AM
Dr. Avram / Strategies for treating Fitzpatrick Skin types 4-6
11:40 AM
Dr. Kilmer / The Newest Generation of Energy Based Devices for Skin
Event Details
  • Date
    Saturday, March 2
  • Time
    9:00 AM - 12:00 PM
  • Location
    Room 147B
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • Kristen Marie Kelly, MD, FAAD - Handout
Speakers
  • Arielle N.B. Kauvar, MD, FAAD
  • Arisa Ortiz, MD, FAAD - Handout
  • Emil A. Tanghetti, MD, FAAD - Handout
  • Jill S. Waibel, MD, FAAD
  • Macrene Alexiades, MD, PhD, FAAD
  • Mathew M. Avram, MD, JD, FAAD
  • Roy G. Geronemus, MD, FAAD
  • Suzanne L. Kilmer, MD, FAAD